The "Canada Next-Generation Sequencing (NGS) Market - A Canada and Regional Analysis: Focus on Application, Technology, ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...
According to MarketsandMarkets™, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in ...
-- Genomics leader relocates to an expanded footprint in Sunnyvale -- New location enables customer continuity and provides increased innovation space to drive growth in MRD and MCED markets -- Newly ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
InvestorsHub on MSN
Charles River Laboratories agrees to buy PathoQuest from SHS Capital
Charles River Laboratories International (NYSE:CRL) said it has reached an agreement to acquire PathoQuest SAS from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback